Sarepta Therapeutics

$71.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.83 (-1.14%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SRPT and other stocks, options, and ETFs commission-free!

About SRPT

Sarepta Therapeutics, Inc. Common Stock (DE), also called Sarepta Therapeutics, is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases.

CEO
Douglas S. Ingram
Employees
866
Headquarters
Cambridge, Massachusetts
Founded
1980
Market Cap
5.50B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
855.76K
High Today
$73.00
Low Today
$70.73
Open Price
$72.41
Volume
670.35K
52 Week High
$181.83
52 Week Low
$68.04

SRPT Earnings

-$1.86
-$1.24
-$0.62
-$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 5, After Hours

You May Also Like

RILYK
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure